Loading…
Beneficient is projected to rise to $3.56 by 2027, a +4% move from its current price of $3.42. BENF is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $3.31 | $3.42 | $3.54 | +0.05% |
| Jul 15 | $3.27 | $3.42 | $3.59 | +0.09% |
| Jul 16 | $3.23 | $3.42 | $3.63 | +0.14% |
| Jul 17 | $3.21 | $3.43 | $3.66 | +0.18% |
| Jul 18 | $3.18 | $3.43 | $3.69 | +0.23% |
| Jul 19 | $3.16 | $3.43 | $3.72 | +0.28% |
| Jul 20 | $3.14 | $3.43 | $3.75 | +0.32% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.14 | $3.43 | $3.75 | +0.32% |
| Week 2 | $3.04 | $3.44 | $3.90 | +0.64% |
| Week 3 | $2.96 | $3.45 | $4.02 | +0.97% |
| Week 4 | $2.90 | $3.46 | $4.13 | +1.29% |
| Week 5 | $2.85 | $3.48 | $4.23 | +1.62% |
| Week 6 | $2.81 | $3.49 | $4.33 | +1.94% |
| Week 7 | $2.77 | $3.50 | $4.42 | +2.27% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Beneficient is a technology-enabled financial services company that provides liquidity solutions and related trustee, custody and trust administrative services to participants in the alternative asset industry in the United States. It operates through three segments Ben Liquidity, Ben Custody, and Customer ExAlt Trusts, and it offers the Ben AltAccess platform for secure, online, end-to-end delivery of each of the Ben business unit products and services. The company serves individual and institutional investors, wealth advisors, and general partners, and is based in Dallas, Texas.
Beneficient also provides Ben Liquidity, which offers alternative asset liquidity and fiduciary financing products; Ben Custody that provides custody and trust administration services to trustees and document custodian services to customers; and Ben Markets, which provides broker-dealer and transfer agency services. In addition, the company offers Ben Insurance Services and Ben Data that provide insurance products/services and data collection, evaluation, and analytics products/services.
Its comprehensive platform and service suite position it to cater to a range of clients within the alternative asset ecosystem, leveraging its technology-enabled approach and specialized offerings.
Beneficient (BENF) trades at $3.31, with a market capitalization of $47.96M and a rank of 4595. The current price sits at the forecasted near-term average for 2026, with a 30-day price range of $2.65 to $4.13 and a technical backdrop that is currently bearish. The forecast trajectory shows a gradual, multi-year path with notable upside potential beginning in the early 2030s, culminating in substantially higher long-horizon prices.
In the near term, the 2026 average price is $3.31, with a neutral sentiment and an ROI of 0 for the year. From 2027 onward, the forecast projects a stepwise rise in average prices and positive ROI in several years, leading to bullish momentum in the mid-2030s and beyond. The long-range view envisions meaningful upside through 2040 and into 2050, albeit with annual volatility and variability across years.
A major floor 13.1% below — a decisive break under it would weaken the trend.
The nearest floor, 3.2% below — buyers have tended to step in here.
The nearest ceiling, 13.2% above — a clean break opens room to run.
A major ceiling 20.2% above — clearing it would confirm fresh momentum.
Key BENF support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BENF market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.50 | Sell | $3.48 | Sell |
| MA 10 | $3.61 | Sell | $3.53 | Sell |
| MA 20 | $3.54 | Sell | $3.54 | Sell |
| MA 50 | $3.50 | Sell | $3.56 | Sell |
| MA 100 | $3.59 | Sell | $3.72 | Sell |
| MA 200 | $4.38 | Sell | $8.44 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 45.21 | Neutral |
| Stoch RSI (14) | 21.07 | Neutral |
| CCI (20) | -70.51 | Neutral |
| Williams %R (14) | -80.36 | Info |
| MACD (12,26,9) | -0.03 | Sell |
| ROC (12) | -1.30 | Sell |
| Bollinger %B (20,2) | 0.28 | Neutral |
| Stochastic %K (14) | 19.64 | Buy |
| TRIX (15) | 0.11 | Buy |
| Awesome (5,34) | -0.06 | Sell |
| Ultimate (7,14,28) | 36.12 | Neutral |
| Momentum (10) | -0.12 | Sell |
| Aroon Osc (25) | -28.00 | Sell |
| Hull MA (9) | 3.37 | Buy |
| ADX (14) | 9.22 | Neutral |
| ATR (14) | 0.10 | Info |
The 30-day technical picture is bearish, with RSI(14) at 40. The simple moving average over 50 days is $3.50, and the 200-day SMA is $4.38. The asset sits on a support level of $3.31 and faces resistance at $3.87. Over the last 30 days, the price has traded between $2.65 and $4.13.
Overall near-term dynamics show downside pressure relative to the current price, with support near the current level providing a potential base for a bounce if buying interest returns. Traders should watch the $3.31 support and $3.87 resistance as key pivots in the coming weeks.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.07 | $3.42 | $4.79 | 0% | Neutral | |
| $2.78 | $3.56 | $4.86 | +4% | Neutral | |
| $2.58 | $3.42 | $4.88 | 0% | Neutral | |
| $2.40 | $3.29 | $4.85 | -4% | Neutral | |
| $2.41 | $3.38 | $5.13 | -1% | Neutral | |
| $2.46 | $3.54 | $5.51 | +3% | Neutral | |
| $2.76 | $4.06 | $6.47 | +19% | Neutral | |
| $3.05 | $4.57 | $7.42 | +34% | Bullish | |
| $2.90 | $4.43 | $7.33 | +30% | Bullish | |
| $2.82 | $4.41 | $7.41 | +29% | Bullish | |
| $3.36 | $5.72 | $10.34 | +67% | Bullish | |
| $4.48 | $8.92 | $17.84 | +161% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $3.07 | $3.42 | $4.04 | +0.00% |
| August 2026 | $2.93 | $3.48 | $4.26 | +1.78% |
| September 2026 | $2.98 | $3.57 | $4.42 | +2.44% |
| October 2026 | $2.92 | $3.52 | $4.41 | -1.36% |
| November 2026 | $2.95 | $3.58 | $4.54 | +1.88% |
| December 2026 | $3.07 | $3.75 | $4.79 | +4.77% |
Click any year to see its month-by-month BENF forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, BENF could reach as high as $4.79, with a base case around $3.42 and support toward $3.07 — roughly 0% from $3.42. Price action looks broadly range-bound.
Expect BENF to range from $2.78 to $4.86 through 2027. The $3.56 average target implies a +4% move from current prices. That is up +4% on the projected 2026 average. A consolidation phase looks the most probable path here.
The BENF price prediction for 2028 points to an average of $3.42 (low $2.58, high $4.88) — a potential gain of 0% on today's $3.42. Price action looks broadly range-bound.
In 2029, BENF is projected to trade between $2.40 and $4.85, averaging $3.29 — a potential decline of -4% from today's $3.42. That is -4% versus the projected 2028 average. A consolidation phase looks the most probable path here.
Beneficient's 2030 outlook centres on $3.38, within a $2.41 to $5.13 range. That is up +3% on the projected 2029 average. That marks a -1% change versus current levels. Price action looks broadly range-bound.
By 2031, BENF could reach as high as $5.51, with a base case around $3.54 and support toward $2.46 — roughly +3% from $3.42. A consolidation phase looks the most probable path here.
Expect BENF to range from $2.76 to $6.47 through 2032. The $4.06 average target implies a +19% move from current prices. That is up +15% on the projected 2031 average. Price action looks broadly range-bound.
The BENF price prediction for 2033 points to an average of $4.57 (low $3.05, high $7.42) — a potential gain of +34% on today's $3.42. Buyers look set to stay in control over this stretch.
In 2034, BENF is projected to trade between $2.90 and $7.33, averaging $4.43 — a potential gain of +30% from today's $3.42. That is -3% versus the projected 2033 average. Momentum favours further upside here.
Beneficient's 2035 outlook centres on $4.41, within a $2.82 to $7.41 range. That is -1% versus the projected 2034 average. That marks a +29% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, BENF could reach as high as $10.34, with a base case around $5.72 and support toward $3.36 — roughly +67% from $3.42. Momentum favours further upside here.
Expect BENF to range from $4.48 to $17.84 through 2050. The $8.92 average target implies a +161% move from current prices. That is up +56% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in BENF today (≈ 292.397661 BENF) could be worth
$2,607.6
+$1,607.6 (+161%) by 2050 · US Dollar
Based on the average projected BENF price of $8.92 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BENFwould be worth at today's price.
$1,000 invested in BENF on Jul 10, 2025 (≈ 416.66665 BENF) would be worth
$1,425
+$425 (+42.5%) today · 1.42× · US Dollar
Based on a BENF entry price of $2.4 vs. today's $3.42.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.64 | $939.56 | -6.0% |
| 1 month ago | $3.45 | $991.3 | -0.9% |
| 3 months ago | $4.08 | $838.24 | -16.2% |
| 6 months ago | $5.34 | $640.45 | -36.0% |
| 1 year ago | $2.4 | $1,425 | +42.5% |
| All time (4.6y) ago | $6,316.8 | $0.54 | -99.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BENF forecast.
Our base-case forecast reaches $6.80 around 2050.
Implied market cap at $6.80: $98.52M
The multi-year forecast shows a gradual rise in the average price after 2026, with several years of neutral to bullish momentum. For 2026 the min, avg, and max are $3.07, $3.31, and $4.67 respectively, with a neutral sentiment and ROI of 0. In 2027 the avg moves to $3.46 with a 4.4 ROI and neutral sentiment, while 2028 shows $3.34 as the avg and a 1 ROI.
2029 projects an avg of $3.21 with a -3 ROI and neutral sentiment, and 2030 shows an avg of $3.27 with a -1.1 ROI and neutral sentiment.
From 2031 onward, the outlook turns more constructive: 2031 avg $3.42 (3.2 ROI, neutral), 2032 avg $3.92 (18.6 ROI, neutral), and 2033 avg $4.44 (34.1 ROI, bullish). The path continues with 2034 avg $4.33 (30.8 ROI, bullish) and 2035 avg $4.29 (29.7 ROI, bullish). The forecast then extends into 2040 with avg $5.58 (68.7 ROI, bullish) and reaches 2050 with avg $8.70 (162.7 ROI, bullish).
These figures imply meaningful upside potential over the longer horizon, balanced by years with negative or modest returns and inherent uncertainty.
Tap a question to reveal the answer.
2030 forecast: min $2.33, avg $3.27, max $4.98, ROI -1.1, sentiment NEUTRAL.
Forecasts show varying ROI across years, including 4.4 in 2027, 18.6 in 2032, 68.7 in 2040, and 162.7 in 2050, with a negative ROI in 2029 (-3) and 2030 (-1.1). The longer horizon projects bullish momentum from the early 2030s, but outcomes are not guaranteed.
The 2050 forecast shows a max of $17.45, with an avg of $8.70 and a min of $4.35. Reaching $10 would be possible within the projected range, but it is not guaranteed.
For 2026, the avg is $3.31 with neutral sentiment and ROI of 0. The 30-day range is $2.65–$4.13, with support at $3.31 and resistance at $3.87. The outlook suggests limited upside in the near term but potential movement as the year progresses.
Current price: $3.31. Market cap: $47.96M. Rank: 4595.
Beneficient Community Discussion
0Share your Beneficient price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.